Despite significant advancements in increasing distribution and development of vaccines against childhood killer diseases — including pneumococcal disease, rotavirus, and Haemophilus influenzae type B — global efforts to reduce the burden of infection from neglected tropical diseases has greatly lagged, argue experts.